|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0033164,
umls-concept:C0175668,
umls-concept:C0180860,
umls-concept:C0205225,
umls-concept:C0220825,
umls-concept:C0301630,
umls-concept:C0581406,
umls-concept:C0699733,
umls-concept:C1510827,
umls-concept:C1522664,
umls-concept:C1546637,
umls-concept:C1550638,
umls-concept:C1704449,
umls-concept:C1704684
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-11-2
|
|
pubmed:abstractText |
A filter (PRF1) designed to remove abnormal prion proteins from red-cell units has been developed. The purpose of this study was to evaluate the quality of red cells produced using this device.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0042-9007
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
220-8
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
In-vitro evaluation of the PALL Leukotrap Affinity Prion Reduction Filter as a secondary device following primary leucoreduction.
|
|
pubmed:affiliation |
Welsh Blood Service, Pontyclun, UK.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
